Portfolio company
Bioinvent
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops antibody-based therapies for cancer treatment for pharmaceutical partners and produces drug substances for clinical trials.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bioinvent International
This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.
Adcendo
This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.
Micromet
This biotechnology firm develops antibody therapies for cancer and autoimmune disease treatment for patients and pharmaceutical partners.
Alligatorbioscience
This biotechnology company develops antibody-based medicines for cancer treatment for patients with metastatic tumours.
ABL Bio
The company develops bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases for pharmaceutical partners and clinical research applications.
Zymeworks
The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.
mAbxience
This company develops and manufactures biosimilar monoclonal antibodies and provides contract development and manufacturing services to partners in the global biopharmaceutical industry.
Araris Biotech
This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.
